The study of Xu et al. [21] confirmed that serum IL-6 might be a potential biomarker for colorectal cancer (CRC) diagnosis, and the high serum IL-6 level was associated with poor prognosis for both CRC overall survival and disease-free survival. This evidence concerns the gene IL6 and colorectal cancer.